(NYSE:NVO), NEW YORK, Aug. 10, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Novo Nordisk A/S (NYSE: NVO) between May 7, 2025 and July 28, 2025, both dates inclusive (the “Class Period”). A class […]
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Novo Nordisk A/S Investors to Secure Counsel Before Important Deadline in Securities Class Action – NVO GlobeNewswire August 10, 2025 NEW YORK, Aug. 10, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers
NEW YORK, NY / ACCESS Newswire / August 10, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Encompass Health Corporation ("Encompass Health Corporation") (NYSE:EHC) concerning possible violations of federal securities laws. On July 15, 2025, the New York Times published an article, entitled "Even Grave Errors at Rehab Hospitals
NEW YORK, NY / ACCESS Newswire / August 10, 2025 / If you suffered a loss on your Hims & Hers Health, Inc. (NYSE:HIMS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/hims-hers-health-inc-lawsuit-submission-form?prid=160667&wire=1&utm_campaign=26 or contact Joseph E. Levi, Esq. via email at
NEW YORK, NY / ACCESS Newswire / August 10, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of GSK plc ("GSK plc") (NYSE:GSK) concerning possible violations of federal securities laws. GSK issued a press release on July 17, 2025, announcing "that the US Food and Drug Administration (FDA) Oncologic Drugs
NEW YORK, NY / ACCESS Newswire / August 10, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Duolingo, Inc. ("Duolingo, Inc.") (NASDAQ:DUOL) concerning possible violations of federal securities laws. On July 28, 2025, JMP Securities lowered its price target on Duolingo stock to $450 from $475, citing concerns about
NEW YORK, NY / ACCESS Newswire / August 10, 2025 / If you suffered a loss on your Sable Offshore Corp. (NYSE:SOC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/sable-offshore-corp-lawsuit-submission-form?prid=160668&wire=1&utm_campaign=16 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or
NEW YORK, NY / ACCESS Newswire / August 10, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Praxis Precision Medicines, Inc. ("Praxis Precision Medicines, Inc.") (NASDAQ:PRAX) concerning possible violations of federal securities laws. Praxis Precision Medicines, Inc. issued a press release on August 4, 2025, announcing its financial results
NEW YORK, NY / ACCESS Newswire / August 10, 2025 / If you suffered a loss on your Tesla, Inc. (NASDAQ:TSLA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/tesla-inc-lawsuit-submission-form-2?prid=160670&wire=1&utm_campaign=3 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call
(NasdaqGM:RCKT), NEW YORK, Aug. 10, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) between September 17, 2024 and May 26, 2025, both dates inclusive (the “Class Period”), of the important August 11, 2025 lead plaintiff deadline. SO WHAT: If